NKTR
NEKTAR THERAPEUTICS SEC filings
Every EDGAR filing for NEKTAR THERAPEUTICS (NKTR), newest first, with AI summaries and stories.
- Ticker
- NKTR
- CIK
- 906709
- Sector
- Biotech and pharma
- Latest filing
- Oct 1
Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 16)
Insider activity
No open-market insider buys in the last 30 days.
Also: 5 grants or exercises.
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KNEKTAR THERAPEUTICSNKTRLIVE ROUTINESCHEDULE 13G/ANEKTAR THERAPEUTICSNKTRLIVE Ownership stake disclosure by Two Seas Capital LP (amended)
Two Seas Capital LP, filed by
ROUTINE4NEKTAR THERAPEUTICSNKTRLIVE 5 insider filings
Roy A Whitfield, insider filing for NKTR
Show all 5
- 4Insider filing for NKTR
- 4Insider filing for NKTR
- 4Insider filing for NKTR
- 4Insider filing for NKTR
- 4Insider filing for NKTR
Roy A Whitfield, reporting
ROUTINE8-KNEKTAR THERAPEUTICSNKTRLIVE ROUTINE8-KNEKTAR THERAPEUTICSNKTRLIVE ROUTINE4NEKTAR THERAPEUTICSNKTRLIVE 2 insider filings
Jonathan Zalevsky, insider filing for NKTR
Show all 2
- 4Insider filing for NKTR
- 4Insider filing for NKTR
Jonathan Zalevsky, reporting
ROUTINE144NEKTAR THERAPEUTICSNKTRLIVE 2 Form 144 notices
Jonathan Zalevsky, planned sale of NKTR shares
Show all 2
- 144Planned insider sale of NKTR shares
- 144Planned insider sale of NKTR shares
Jonathan Zalevsky, reporting
ROUTINESCHEDULE 13G/ANEKTAR THERAPEUTICSNKTRLIVE 2 13G filings
Ownership stake disclosure by Two Seas Capital LP (amended)
Show all 2
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
Two Seas Capital LP, filed by
ROUTINES-8NEKTAR THERAPEUTICSNKTRLIVE ROUTINE8-KNEKTAR THERAPEUTICSNKTRLIVE ROUTINESCHEDULE 13GNEKTAR THERAPEUTICSNKTRLIVE Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC, filed by
ROUTINESCHEDULE 13GNEKTAR THERAPEUTICSNKTRLIVE Ownership stake disclosure by BlackRock, Inc.
BlackRock, Inc., filed by
ROUTINE4NEKTAR THERAPEUTICSNKTRLIVE 2 insider filings
Jonathan Zalevsky, insider filing for NKTR
Show all 2
- 4Insider filing for NKTR
- 4Insider filing for NKTR
Jonathan Zalevsky, reporting
ROUTINE4NEKTAR THERAPEUTICSNKTRLIVE Jonathan Zalevsky, insider filing for NKTR
Jonathan Zalevsky, reporting
ROUTINE144NEKTAR THERAPEUTICSNKTRLIVE Jonathan Zalevsky, planned sale of NKTR shares
Jonathan Zalevsky, reporting
ROUTINE4NEKTAR THERAPEUTICSNKTRLIVE Howard W Robin, insider filing for NKTR
Howard W Robin, reporting
ROUTINE4NEKTAR THERAPEUTICSNKTRLIVE Jonathan Zalevsky, insider filing for NKTR
Jonathan Zalevsky, reporting
ROUTINE144NEKTAR THERAPEUTICSNKTRLIVE Howard W Robin, planned sale of NKTR shares
Howard W Robin, reporting
ROUTINE144NEKTAR THERAPEUTICSNKTRLIVE Howard W Robin, planned sale of NKTR shares
Howard W Robin, reporting
ROUTINE144NEKTAR THERAPEUTICSNKTRLIVE Jonathan Zalevsky, planned sale of NKTR shares
Jonathan Zalevsky, reporting
ROUTINE8-KNEKTAR THERAPEUTICSNKTRLIVE ROUTINE3NEKTAR THERAPEUTICSNKTRLIVE Linda M Rubinstein, new insider at NKTR
Linda M Rubinstein, reporting
ROUTINE4NEKTAR THERAPEUTICSNKTRLIVE 2 insider filings
Jonathan Zalevsky, insider filing for NKTR
Show all 2
- 4Insider filing for NKTR
- 4Insider filing for NKTR
Jonathan Zalevsky, reporting
ROUTINE144NEKTAR THERAPEUTICSNKTRLIVE 2 Form 144 notices
Jonathan Zalevsky, planned sale of NKTR shares
Show all 2
- 144Planned insider sale of NKTR shares
- 144Planned insider sale of NKTR shares
Jonathan Zalevsky, reporting
ROUTINESCHEDULE 13G/ANEKTAR THERAPEUTICSNKTRLIVE Ownership stake disclosure by BIOTECHNOLOGY VALUE FUND L P (amended)
BIOTECHNOLOGY VALUE FUND L P, filed by
ROUTINE424B5NEKTAR THERAPEUTICSNKTRLIVE ROUTINE8-KNEKTAR THERAPEUTICSNKTRLIVE ROUTINE8-KNEKTAR THERAPEUTICSNKTRLIVE ROUTINESCHEDULE 13G/ANEKTAR THERAPEUTICSNKTRLIVE Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by
ROUTINEARSNEKTAR THERAPEUTICSNKTRLIVE ROUTINEDEFA14ANEKTAR THERAPEUTICSNKTRLIVE ROUTINEDEF 14ANEKTAR THERAPEUTICSNKTRLIVE ROUTINE8-KNEKTAR THERAPEUTICSNKTRLIVE ROUTINE424B5NEKTAR THERAPEUTICSNKTRLIVE ROUTINE424B5NEKTAR THERAPEUTICSNKTRLIVE ROUTINE8-KNEKTAR THERAPEUTICSNKTRLIVE ROUTINE8-KNEKTAR THERAPEUTICSNKTRLIVE ROUTINESCHEDULE 13GNEKTAR THERAPEUTICSNKTRLIVE Ownership stake disclosure by Two Seas Capital LP
Two Seas Capital LP, filed by
ROUTINESCHEDULE 13G/ANEKTAR THERAPEUTICSNKTRLIVE Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
ROUTINE144NEKTAR THERAPEUTICSNKTRLIVE Mark Andrew Wilson, planned sale of NKTR shares
Mark Andrew Wilson, reporting